Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study.
Uphaus T, Steffen F, Muthuraman M, Ripfel N, Fleischer V, Groppa S, Ruck T, Meuth SG, Pul R, Kleinschnitz C, Ellwardt E, Loos J, Engel S, Zipp F, Bittner S. Uphaus T, et al. Among authors: zipp f. EBioMedicine. 2021 Oct;72:103590. doi: 10.1016/j.ebiom.2021.103590. Epub 2021 Sep 24. EBioMedicine. 2021. PMID: 34571362 Free PMC article.
Multiple sclerosis - candidate mechanisms underlying CNS atrophy.
Siffrin V, Vogt J, Radbruch H, Nitsch R, Zipp F. Siffrin V, et al. Among authors: zipp f. Trends Neurosci. 2010 Apr;33(4):202-10. doi: 10.1016/j.tins.2010.01.002. Epub 2010 Feb 12. Trends Neurosci. 2010. PMID: 20153532 Review.
Independent replication of STAT3 association with multiple sclerosis risk in a large German case-control sample.
Lill CM, Schjeide BM, Akkad DA, Blaschke P, Winkelmann A, Gerdes LA, Hoffjan S, Luessi F, Dörner T, Li SC, Steinhagen-Thiessen E, Lindenberger U, Chan A, Hartung HP, Aktas O, Lohse P, Kümpfel T, Kubisch C, Epplen JT, Zettl UK, Bertram L, Zipp F. Lill CM, et al. Among authors: zipp f. Neurogenetics. 2012 Feb;13(1):83-6. doi: 10.1007/s10048-011-0305-6. Epub 2011 Nov 18. Neurogenetics. 2012. PMID: 22095036
Remyelinating strategies in multiple sclerosis.
Luessi F, Kuhlmann T, Zipp F. Luessi F, et al. Among authors: zipp f. Expert Rev Neurother. 2014 Nov;14(11):1315-34. doi: 10.1586/14737175.2014.969241. Expert Rev Neurother. 2014. PMID: 25331418 Review.
Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: a multi-center, retrospective analysis.
Grey Née Cotte S, Salmen Née Stroet A, von Ahsen N, Starck M, Winkelmann A, Zettl UK, Comabella M, Montalban X, Zipp F, Fleischer V, Kruse N, Gold R, Chan A. Grey Née Cotte S, et al. Among authors: zipp f. J Neuroimmunol. 2015 Jan 15;278:277-9. doi: 10.1016/j.jneuroim.2014.11.017. Epub 2014 Nov 20. J Neuroimmunol. 2015. PMID: 25468777
A human post-mortem brain model for the standardization of multi-centre MRI studies.
Droby A, Lukas C, Schänzer A, Spiwoks-Becker I, Giorgio A, Gold R, De Stefano N, Kugel H, Deppe M, Wiendl H, Meuth SG, Acker T, Zipp F, Deichmann R. Droby A, et al. Among authors: zipp f. Neuroimage. 2015 Apr 15;110:11-21. doi: 10.1016/j.neuroimage.2015.01.028. Epub 2015 Jan 14. Neuroimage. 2015. PMID: 25595502
401 results